ISSN: 2165-7890
Theodora Margaret*
The number of studies investigating neurotransmitters in autism spectrum disorder (ASD) has increased in recent years, whereas previous studies primarily focused on cerebral blood flow and glucose metabolism. The underlying and contributing causes of ASD are mostly unknown, and the behavioural phenotype is used to diagnose ASD. The discovery of biochemical endophenotypes would be a watershed moment in autism research, paving the way for ASD subtype differentiation and innovative therapeutic medication development. The study recommends future research areas for better understanding the aetiology and pathophysiology of autism spectrum disorder (ASD), as well as pharmacologic and psychosocial therapies for ASD throughout life. In the last few years, there has been a sea change in our understanding of ASD neurobiology, genetics, early detection, and intervention. Recent rises in ASD prevalence estimates, on the other hand, underline the critical need to continue efforts to transform new ASD discoveries into effective interventions for all people with ASD.